Stoke Therapeutics, Inc. · NASDAQ:STOK

Lynx1 Capital Management LP reported a 6.50% stake in Stoke Therapeutics, Inc. (Schedule 13G/A)

Event Jun 30, 2026 · Filed Aug 14, 2026

Lynx1 Capital Management LP reported a 6.50% stake in Stoke Therapeutics, Inc., 4,038,404 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).

Stake
6.50%
Shares
4,038,404
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Lynx1 Capital Management LP6.50%4,038,404
Weston Nichols6.50%4,038,404

Source

View original at SEC

Related